Larkspur Biosciences Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
9
Larkspur Biosciences General Information
Description
Developer of immunotherapies designed to support cancer treatment. The company's immunotherapy for molecularly defined patient populations targets the key intersection between the tumor and the immune system, enabling patients to develop a robust and sustained immune response in colorectal cancer and beyond.
Contact Information
Website
www.larkspur.bioCorporate Office
- One Canal Park
- Suite 210
- Cambridge, MA 02141
- United States
Corporate Office
- One Canal Park
- Suite 210
- Cambridge, MA 02141
- United States
Larkspur Biosciences Timeline
Larkspur Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 03-Jun-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Early Stage VC (Series A) | 23-May-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | $5M | $5M | Completed | Generating Revenue | ||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Larkspur Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Larkspur Biosciences Comparisons
Industry
Financing
Details
Larkspur Biosciences Competitors (1)
One of Larkspur Biosciences’s competitors is AsherBio, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AsherBio | Venture Capital-Backed | South San Francisco, CA |
Larkspur Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Larkspur Biosciences Patents
Larkspur Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026090447-A1 | Phosphonic acid and ester compounds and uses thereof | Pending | 24-Oct-2024 | ||
| WO-2026006446-A1 | Lung cancer cell immune evasion signatures and uses thereof | Pending | 26-Jun-2024 | ||
| WO-2025059584-A1 | Cancer cell immune evasion signatures and uses thereof | Inactive | 15-Sep-2023 | ||
| AU-2024270215-A1 | Inhibitors and degraders of pip4k protein | Pending | 10-May-2023 | ||
| EP-4709720-A1 | Inhibitors and degraders of pip4k protein | Pending | 10-May-2023 | C07D239/42 |
Larkspur Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Larkspur Biosciences Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Termeer Institute | Accelerator/Incubator | |||
| 3E Bioventures Capital | Venture Capital | Minority | ||
| Creacion Ventures | Venture Capital | Minority | ||
| Med-Fine Capital | Venture Capital | Minority | ||
| Polaris Partners | Venture Capital | Minority |
Larkspur Biosciences FAQs
-
When was Larkspur Biosciences founded?
Larkspur Biosciences was founded in 2020.
-
Where is Larkspur Biosciences headquartered?
Larkspur Biosciences is headquartered in Cambridge, MA.
-
What is the size of Larkspur Biosciences?
Larkspur Biosciences has 19 total employees.
-
What industry is Larkspur Biosciences in?
Larkspur Biosciences’s primary industry is Drug Delivery.
-
Is Larkspur Biosciences a private or public company?
Larkspur Biosciences is a Private company.
-
What is Larkspur Biosciences’s current revenue?
The current revenue for Larkspur Biosciences is .
-
How much funding has Larkspur Biosciences raised over time?
Larkspur Biosciences has raised $35.5M.
-
Who are Larkspur Biosciences’s investors?
Termeer Institute, 3E Bioventures Capital, Creacion Ventures, Med-Fine Capital, and Polaris Partners are 5 of 9 investors who have invested in Larkspur Biosciences.
-
Who are Larkspur Biosciences’s competitors?
AsherBio is a competitor of Larkspur Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
